Research & Development Pipeline Strategy

We help  companies navigate the challenge of internal product development from research to market launch. We operate where science and business intersect and we utilize our experience to provide a customized strategy that will help accelerate your product’s path to market.
A pharmaceutical R&D pipeline is formed by combining several assets. It can include:
  • discovery,
  • pre-clinical and development stage,
  • small molecules,  biologics (Phase I-IV) and medical devices.
 
Smaller companies may have only a single project or platform. Large pharma or biotech organizations many times have diverse portfolios with numerous projects at various stages of development. 

CASE STUDY 

________________________

Research & Development Portfolio Strategy: Why Some In-Licensing Deals May Put Your Portfolio At Higher Risk

CASE STUDY 

_______________________

Revitaling Your Commercial Portfolio: How Repurposing Underperforming Products

Might Be An Option

The size of the company and portfolio dictates the complexity and work intensity of the portfolio management. Relevant decisions are made according to a predetermined process and by evaluating multiple parameters. Some portfolio management components may be outsourced. 
We can help with:

© 2023 by James Consulting. Proudly created with Wix.com